A A retrospective study on the effectiveness of active surveillance, control and prevention of the outbreak of COVID-19 in rural communities, Ron Phibun District Nakhon Si Thammarat Province

Authors

  • Siritun Thunboonyakid
  • Phnom Sukchan
  • Tanes Sangsri

Keywords:

COVID-19 outbreak, active surveillance, spider-web-communication, active case finding, control and prevention

Abstract

The spread of Coronavirus disease 2019 (COVID -19) has had a significant impact on public health, medical, social, and economic systems. This study aimed to analyze the utilized multiple interventions and control measures for the outbreak of COVID-19 in the rural community, Ron Phibun district, Nakhon Si Thammarat Province. A descriptive study was conducted to review all laboratory-confirmed COVID-19 case investigation reports and identify active measures from April 24 to May 20, 2021. A total of 80 laboratory-confirmed COVID-19 cases were identified in the Ron Phibun district; 80 cases were detected via active surveillance measures, with 17 (21.25%) identified through active case finding, 33 (41.25%) through close contact tracing, and 30 (37.5%) through the surveillance system. The median age of 80 cases was 39 years (Q1=19, Q3=51). The analytic result showed that the group of household contacts and Buddhist ordination ceremony of the confirmed cases had a higher risk of SARS-CoV-2 infection than community contacts. This study indicated that prevention and mitigation of a super-spreading event require decisions that are based first and foremost on quickly recognizing and comprehending these events, especially in healthcare settings, identifying and mitigating high-risk settings, and strict adherence to active measures. Suggestions based on research findings to inform public health policies should be strengthened timely implementation of nonpharmaceutical interventions could all help in the prevention and control of the COVID-19 outbreak, and when future infectious disease outbreaks in a similar context.

References

Abdullahi, L., Onyango, J. J., Mukiira, C., Wamicwe, J., Githiomi, R., Kariuki, D., . . . Mayieka, L. (2020). Community interventions in Low-And Middle-Income Countries to inform COVID-19 control implementation decisions in Kenya: A rapid systematic review. PLoS One, 15(12), e0242403.

Bian, L., Gao, Q., Gao, F., Wang, Q., He, Q., Wu, X., . . . Liang, Z. (2021). Impact of the Delta variant on vaccine efficacy and response strategies. Expert Rev Vaccines, 20(10), 1201-1209.

CDC. (2021) (A). The Coronavirus Disease 2019 Situation. Retrieved May 2021 from: https://ddc.moph.go.th/viralpneumonia/eng/file/situation/situation-no460-130464.pdf.

CDC. (2021) (B). Thai guidelines for surveillance and investigation of Coronavirus Disease 2019 (COVID-19). Retrieved April 10, 2021 from: https://ddc.moph.go.th/viralpneumonia/eng /file/guidelines/g_surveillance_150520.pdf.

Goh, K. T., Cutter, J., Heng, B. H., Ma, S., Koh, B. K., Kwok, C., . . . Chew, S. K. (2006). Epidemiology and control of SARS in Singapore. Annals of the Academy of Medicine, Singapore, 35(5), 301-316.

Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., …. He, J. X., (2020). China Medical Treatment Expert Group for Clinical Characteristics of Coronavirus Disease 2019 in China. The New England Journal of Medicine, 382(18), 1708-1720.

Guzzetta, G., Riccardo, F., Marziano, V., Poletti, P., Trentini, F., Bella, A., . . . Merler, S. (2021). Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy. Emerging Infectious Diseases, 27(1), 267-270.

Islam, N., Sharp, S. J., Chowell, G., Shabnam, S., Kawachi, I., Lacey, B., . . . White, M. (2020). Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries. British Medical Journal, 370, m2743.

Klompas, M. (2020). Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible. Annals of Internal Medicine, 172(9), 619-620.

Lai, S., Ruktanonchai, N. W., Zhou, L., Prosper, O., Luo, W., Floyd, J. R., . . . Tatem, A. J. (2020). Effect of non-pharmaceutical interventions to contain COVID-19 in China. Nature, 585(7825), 410-413.

Liu, H., Ye, C., Wang, Y., Zhu, W., Shen, Y., Xue, C., . . . Zhou, Y. (2021). The effectiveness of active surveillance measures for COVID-19 cases in Pudong New Area Shanghai, China, 2020. Journal of Medical Virology, 93(5), 2918-2924.

Lopez, B.J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., . . . Ramsay, M. (2021). Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. The New England Journal of Medicine, 385(7), 585-594.

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., . . . Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. The Journal of the American Medical Association, 323(11), 1061-1069.

WHO. (2020) WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020. Retrieved May 2021 from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.

WHO. (2021) (A). Coronavirus disease 2019 (COVID-19). Situation Report-1. Retrieved May 2021 from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf.

WHO. (2021) (B). Coronavirus disease 2019 (COVID-19) WHO Thailand Situation Report–22. Retrieved May 2021 from: https://www.who.int/docs/default-source/searo/thailand/2020-03-15-tha-sitrep-22-covid19.pdf.

WHO. (2021) (C). Coronavirus disease 2019 (COVID-19). Retrieved April 2021 from: https://cdn.who.int/media/docs/default-source/searo/thailand/2021_01_07_tha-sitrep-117-covid19.pdf?sfvrsn=d7ba2976_3.

Wong, J. E. L., Leo, Y. S., & Tan, C. C. (2020). COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action. The Journal of the American Medical Association, 323(13), 1243-1244.

Xu, X., Liu, X., Wang, L., Ali, S. T., Du, Z., Bosetti, P., . . . Wu, Y. (2020). Household transmissions of SARS-CoV-2 in the time of unprecedented travel lockdown in China. medRxiv.

Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., . . . Shang, Y. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine, 8(5), 475-481.

Zhou, F., You, C., Zhang, X., Qian, K., Hou, Y., Gao, Y., & Zhou, X. H. (2021). Epidemiological Characteristics and Factors Associated with Critical Time Intervals of COVID-19 in Eighteen Provinces, China: A Retrospective Study. International Journal of Infectious Diseases, 102, 123-131.

Additional Files

Published

2023-05-15

How to Cite

Thunboonyakid, S., Sukchan, P., & Sangsri, T. (2023). A A retrospective study on the effectiveness of active surveillance, control and prevention of the outbreak of COVID-19 in rural communities, Ron Phibun District Nakhon Si Thammarat Province. Princess of Naradhiwas University Journal, 15(2), 225–242. Retrieved from https://li01.tci-thaijo.org/index.php/pnujr/article/view/255133

Issue

Section

Research Articles